Chicago

Chicago, Illinois 60640

1 studies enrolling now · 10 studies all time

What they study most

Aging, C. Diff, C. Difficile, CDI, Chronic Obstructive Pulmonary Disease, Clostridium Difficile Infection, Clostridium Difficile Infection Recurrence, Contraception, Endometriosis, FMT, Fecal Microbiota, Fecal Transplant

Studies at this site

• A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis — Recruiting now
• Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for Pregnancy — Completed
• Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids — Completed
• Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD — Stopped early
• LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids — Completed
• Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff — Completed
• Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection — Completed
• LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids — Completed
• RHA® Redensity With New Anesthetic Agent - Perioral Rhytids — Completed
• Safety and Efficacy of Adipose Derived Stem Cells for Chronic Obstructive Pulmonary Disease — Completed